2012
Antigen-specific immunotherapy for ovarian cancer
Roque D, Santin A. Antigen-specific immunotherapy for ovarian cancer. 2012, 136-154. DOI: 10.2217/ebo.11.180.Peer-Reviewed Original ResearchOvarian cancer immunotherapyAntigen-specific immunotherapyTumor-associated antigensCancer immunotherapyOvarian tumor-associated antigensSpecific T cell responsesCritical immune checkpointsRegulatory T cellsT cell responsesOvarian cancer pathogenesisB7 family proteinsImmune checkpointsClinical trialsOvarian cancerT cellsImmune responseSuccessful therapyInhibitory pathwaysImmune evasionImmunotherapySpecific antigenHost defenseCancer pathogenesisAntigenTumors
2002
Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer.
Santin AD, Bellone S, Underwood LJ, O'Brien TJ, Ravaggi A, Pecorelli S, Cannon MJ. Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer. Minerva Obstetrics And Gynecology 2002, 54: 133-44. PMID: 12032451.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntigens, NeoplasmCancer VaccinesChildClinical Trials as TopicCombined Modality TherapyDendritic CellsFemaleGPI-Linked ProteinsHumansImmunohistochemistryImmunotherapyKallikreinsMatrix Metalloproteinase 7Membrane ProteinsNeoplasm MetastasisOvarian NeoplasmsSerine EndopeptidasesT-Lymphocytes, CytotoxicTumor Cells, CulturedConceptsTumor antigensOvarian cancerChemotherapy-resistant ovarian cancerOvarian tumor-associated antigensDendritic cell-based immunotherapyTumor-specific immune responsesEffective tumor antigensTherapeutic DC vaccinationNovel immunotherapeutic strategiesStandard treatment modalityCell-based immunotherapyOvarian tumor antigenSpecific immune responseTumor-associated antigensPotential of DCDC vaccinationImmunotherapeutic strategiesDendritic cellsCancer vaccinationCancer patientsGynecologic oncologyTreatment modalitiesNatural adjuvantImmune responseAntigen preparations